CONTACT US

Address
33 Whitehall St, 7th Floor
New York, NY 10004
General
info@foodworldnews.com
Advertising Inquiries
ads@foodworldnews.com
Partnerships
business@foodworldnews.com
Feedback
feedback@foodworldnews.com
Food Biz
The second largest fastfood chain in the world will launch its first stores in India in the coming months.  Target locations will be New Delhi, Mumbai and NCR.

Burger King India Soon To Open In Coming Months

The second largest fastfood chain in the world will launch its first stores in India in the coming months. Target locations will be New Delhi, Mumbai and NCR.

Panera cuts 2014 profit forecast, shares slip

Panera Cuts 2014 Profit Forecast, Shares Slip

Panera Bread Co (PNRA.O) on Tuesday lowered its full-year earnings forecast as it works to speed up service at its popular bakery cafes.

Papa John’s CEO At Funeral Of Ruthlessly Killed Employee At Late Shift In Pizza Store

Papa John’s CEO At Funeral Of Ruthlessly Killed Employee At Late Shift In Pizza Store

Papa John’s CEO At Funeral – John Schnatter, the founder and CEO of Papa John’s, attended a funeral held in commemoration of Gordon Schaffer’s recent passing on Sat.

Food Tech
Swiss-based food giant Nestlé is hiring 1,000 humanoid robots as sales clerks at stores across Japan.

Nestle To Hire 1,000 Humanoid Robots In Japan For Selling Coffee And Home Espresso Machines

The first batch of robots which will be called as Pepper will be assigned on their stations at the end of the year to sell home espresso machines and coffee capsules.

"Mooncake Hot Pot" And "Mooncake Salad" Appear In Chongqing

Brain’s Calorie Counter: The Reason Behind Craving Junk Food

A new study has found that there is such a thing as the brain’s calorie counter, which explains why the brain has a tendency to choose junk food over healthier one, as it’s attempting to fill a quota. The discovery of the brain’s calorie counter explains the body’s need for fatty foods, beyond the fact that these types of meals are cheaper.

Food and Drug Administration

FDA Seeks More Data On Sarepta Muscle Disorder Drug, Shares Slump

Sarepta Therapeutics Inc said the U.S. Food and Drug Administration had asked for additional data on its lead drug, delaying its marketing application by about six months.

Real Time Analytics